The Atlantic examines 'paradigm shift' in global health response

"The world has an 'historic opportunity' to contain and end three of humanity's deadliest scourges by focusing on their 'hot zones,' according to Mark Dybul, the newly appointed director of the Geneva-based Global Fund to Fight AIDS, Tuberculosis, and Malaria," the Atlantic reports in an article examining a "paradigm shift" in the global health response. "Dybul said that a better understanding of the epidemiology of the diseases makes it clear there aren't what have been called 'generalized' epidemics, even in hard-hit countries, but there are what he called 'micro-epidemics,'" the magazine writes, noting the shift, "first modeled in the PEPFAR program ... also focuses on delivering measurable results, such as how much mortality has declined and how many new infections have been averted" (Andriote, 2/13).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Spermidine regulates RIPK1 to combat diabetes and vascular damage